Osteopore Limited announced changes to its board of directors. The company announced that it has accepted the resignation of non-executive Chairman, Brett Sandercock, effective 1 August 2021. Mr. Sandercock has been a valued member of the Board since June 2019, and his support was instrumental in the listing of the Company on the Australian Securities Exchange (ASX). Since listing, Mr. Sandercock has continued to serve as non-executive Chairman and from this position has provided both strategic and operational guidance for the Company's growth. Coinciding with Mr. Sandercock's resignation, the company announced that it has secured the experienced corporate executive Mark Leong as chairman and non-executive director. Mr. Leong is a Fellow of the Association of Chartered Certified Accountants (ACCA), Chartered Accountant of the Institute of Singapore Chartered Accountants (ISCA) and Member of the Singapore Institute of Directors (SID).